Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $8.10 and traded as low as $7.16. Hypera shares last traded at $7.40, with a volume of 2,895 shares trading hands.
Analyst Ratings Changes
Separately, Morgan Stanley lowered shares of Hypera from an "overweight" rating to an "equal weight" rating in a research note on Friday, March 10th.
Get Hypera alerts:Hypera Trading Down 1.3 %
The business's fifty day moving average price is $8.07 and its 200 day moving average price is $8.38.
About Hypera
(Get Rating)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat Week in Review – 4/3 – 4/7
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here's Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.